Literature DB >> 20843170

Toxicity manifesting as cosmetic hair alterations during erlotinib treatment.

Kenichiro Kudo, Keiichi Fujiwara, Mizuho Tsushima, Makoto Mizuta, Kiyoshi Matsuo, Toshiro Yonei, Toshio Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20843170     DOI： 10.3109/0284186X.2010.509107

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

Review 1.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

2.  Scanning Electron Microscopy of Erlotinib-induced Hair Changes: Pili Torti et Canaliculi.

Authors:  Hiram Larangeira de Almeida; Débora Sarzi Sartori; Renan Pinheiro Deves; Otávio Martins Cruz
Journal:  Int J Trichology       Date:  2019 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.